MetaCap

BlackRock Capital Allocation Term Trust (BCAT)

NYSE: BCATFinanceFinance/Investors ServicesUSD

11.36-0.58 (-4.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BCAT stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
26.42% ($0.00)
Ex-dividend date
Nov 13, 2026
52-week range
11.36 – 16.20
Day range
11.36 – 11.87
Volume / Avg
1.57M / 850.92K
Beta
—

52-week range

$11.36$16.20

BCAT stock today

Shares of BlackRock Capital Allocation Term (BCAT) finished lower on Nov 20 at $11.36, a drop of 4.86% or $0.58 per share, versus the S&P 500's 3.70% decline. At this level, BCAT sits near the bottom of its 52-week range of $11.36 to $16.20: 29.9% below the high, set on Aug 13, 2026 and 0.0% above the low. BCAT is down 19.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 18.5%.

At 4.8x trailing earnings, BlackRock Capital Allocation Term trades in line with the peer-group median of 4.5x.

Summary generated from market data by MetaCap's automated system. Methodology

About BlackRock Capital Allocation Term

Company profile
Sector
Finance
Industry
Finance/Investors Services
Headquarters
New York, NY
IPO year
2020

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.25
Ex-dividend date
Nov 13, 2026

BlackRock Capital Allocation Term peers

Finance sector

Indexes, lists and sector

BlackRock Capital Allocation Term stock FAQ

What is BlackRock Capital Allocation Term's stock price today?

BCAT last traded at $11.36 as of Nov 20, 4:00 PM EST, down 4.86% on the day. Prices are delayed at least 15 minutes.

Does BlackRock Capital Allocation Term pay a dividend?

Yes. BlackRock Capital Allocation Term pays $0.00 per share annually, a 26.42% yield. The most recent dividend of $0.25 had an ex-dividend date of Nov 13, 2026.

What is BCAT's P/E ratio?

BCAT trades at a trailing P/E ratio of 4.77, compared with a median of 4.5 for its closest peers.

What is the BCAT 52-week high?

The 52-week high for BCAT is $16.20 and the 52-week low is $11.36. The stock is currently 29.9% below its high.

Compare BCAT